| Patent No: | US11970699 [USA] | Application No: | US18049291 |
| Title: | Kinetically enhanced engineered fncas9 and its uses thereof | ||
| Issue Date: | 30-04-2024 | File Date: | 25-10-2022 |
| Inventor(s): | Chakraborty, Debojyoti; Maiti, Souvik; Nureki, Osamu; Nishimasu, Hiroshi; Acharya, Sundaram; Hirano, Seichi; Hisato, Hirano | ||
| IPC Classification: | C12N 001552, C12N 000922 | ||
| Abstract: | Engineered FnCas9 variants are provided that have an enhanced kinetic activity and a broader PAM recognition. The protein engineering methodology introduced specific mutations that stabilized interaction between Cas9 enzyme and target DNA. The enhanced kinetic activity increases NHEJ-mediated editing, owing to more efficient DSB generation potential than WT FnCas9, and the broadened PAM specificity increases the target range of FnCas9 variants. Thus, the scope and accessibility of CRISPR-Cas9 system targets are widened, along with generating robust and highly specific engineered FnCas9 variants. |
||